4pis
From Proteopedia
(Difference between revisions)
m (Protected "4pis" [edit=sysop:move=sysop]) |
|||
| (6 intermediate revisions not shown.) | |||
| Line 1: | Line 1: | ||
| - | '''Unreleased structure''' | ||
| - | + | ==Crystal structure of human adenovirus 8 protease in complex with a nitrile inhibitor== | |
| + | <StructureSection load='4pis' size='340' side='right'caption='[[4pis]], [[Resolution|resolution]] 2.10Å' scene=''> | ||
| + | == Structural highlights == | ||
| + | <table><tr><td colspan='2'>[[4pis]] is a 2 chain structure with sequence from [https://en.wikipedia.org/wiki/Human_adenovirus_D8 Human adenovirus D8]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=4PIS OCA]. For a <b>guided tour on the structure components</b> use [https://proteopedia.org/fgij/fg.htm?mol=4PIS FirstGlance]. <br> | ||
| + | </td></tr><tr id='method'><td class="sblockLbl"><b>[[Empirical_models|Method:]]</b></td><td class="sblockDat" id="methodDat">X-ray diffraction, [[Resolution|Resolution]] 2.1Å</td></tr> | ||
| + | <tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat" id="ligandDat"><scene name='pdbligand=3FU:N~2~-[(2R)-2-(3,5-DICHLOROPHENYL)-2-(DIMETHYLAMINO)ACETYL]-N-({2-[(Z)-IMINOMETHYL]PYRIMIDIN-4-YL}METHYL)-L-ISOLEUCINAMIDE'>3FU</scene></td></tr> | ||
| + | <tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=4pis FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=4pis OCA], [https://pdbe.org/4pis PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=4pis RCSB], [https://www.ebi.ac.uk/pdbsum/4pis PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=4pis ProSAT]</span></td></tr> | ||
| + | </table> | ||
| + | == Function == | ||
| + | [https://www.uniprot.org/uniprot/B9A5C1_ADE08 B9A5C1_ADE08] | ||
| + | <div style="background-color:#fffaf0;"> | ||
| + | == Publication Abstract from PubMed == | ||
| + | The cysteine protease adenain is the essential protease of adenovirus and, as such, represents a promising target for the treatment of ocular and other adenoviral infections. Through a concise two-pronged hit discovery approach we identified tetrapeptide nitrile 1 and pyrimidine nitrile 2 as complementary starting points for adenain inhibition. These hits enabled the first high-resolution X-ray cocrystal structures of adenain with inhibitors bound and revealed the binding mode of 1 and 2. The screening hits were optimized by a structure-guided medicinal chemistry strategy into low nanomolar drug-like inhibitors of adenain. | ||
| - | + | Discovery and structure-based optimization of adenain inhibitors.,Mac Sweeney A, Grosche P, Ellis D, Combrink K, Erbel P, Hughes N, Sirockin F, Melkko S, Bernardi A, Ramage P, Jarousse N, Altmann E ACS Med Chem Lett. 2014 Jun 20;5(8):937-41. doi: 10.1021/ml500224t. eCollection, 2014 Aug 14. PMID:25147618<ref>PMID:25147618</ref> | |
| - | + | From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.<br> | |
| + | </div> | ||
| + | <div class="pdbe-citations 4pis" style="background-color:#fffaf0;"></div> | ||
| + | == References == | ||
| + | <references/> | ||
| + | __TOC__ | ||
| + | </StructureSection> | ||
| + | [[Category: Human adenovirus D8]] | ||
| + | [[Category: Large Structures]] | ||
| + | [[Category: Altmann E]] | ||
| + | [[Category: Bernardi A]] | ||
| + | [[Category: Combrink K]] | ||
| + | [[Category: Ellis D]] | ||
| + | [[Category: Erbel P]] | ||
| + | [[Category: Grosche P]] | ||
| + | [[Category: Hughes N]] | ||
| + | [[Category: Jarousse N]] | ||
| + | [[Category: Mac Sweeney A]] | ||
| + | [[Category: Melkko S]] | ||
| + | [[Category: Ramage P]] | ||
| + | [[Category: Sirockin F]] | ||
Current revision
Crystal structure of human adenovirus 8 protease in complex with a nitrile inhibitor
| |||||||||||
Categories: Human adenovirus D8 | Large Structures | Altmann E | Bernardi A | Combrink K | Ellis D | Erbel P | Grosche P | Hughes N | Jarousse N | Mac Sweeney A | Melkko S | Ramage P | Sirockin F
